APA (7th ed.) Citation

A, M., I, V., I, C., JM, R., B, A., C, J., . . . R, G. (2024). The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression. Blood cancer journal, 14(1), 74. https://doi.org/10.1038/s41408-024-01053-3

Chicago Style (17th ed.) Citation

A, Medina-Herrera, et al. "The Genomic Profiling of High-risk Smoldering Myeloma Patients Treated with an Intensive Strategy Unveils Potential Markers of Resistance and Progression." Blood Cancer Journal 14, no. 1 (2024): 74. https://doi.org/10.1038/s41408-024-01053-3.

MLA (9th ed.) Citation

A, Medina-Herrera, et al. "The Genomic Profiling of High-risk Smoldering Myeloma Patients Treated with an Intensive Strategy Unveils Potential Markers of Resistance and Progression." Blood Cancer Journal, vol. 14, no. 1, 2024, p. 74, https://doi.org/10.1038/s41408-024-01053-3.